PhaseV Trials
Latest round
- Series A
Last raised
- May 2025
Total raised
- $65M
Investors
- 6
About PhaseV Trials
Based in Tel Aviv, Israel, and co-founded by Raviv Pryluk (CEO), Elad Berkman (CTO), and Dan Goldstaub in 2023, PhaveV Trials Ltd. operates as a provider of machine learning (ML) technology for adaptive clinical trial design and closed-loop execution. In May 2025, PhaseV Trials Ltd. The company is dedicated to developing technologies, statistical methods, and ML-based platforms for adaptive clinical trial design and execution. Their approach is built on the principles of Exploration-Exploitation with Multi-Arm-Bandit, real-time optimization with Modern Software, and detecting hidden signals with Causal-ML. Additionally, PhaseV leverages ML to provide data-driven, actionable clinical insights at any point during a trial and provide recommendations for optimal trial designs. The company also helps increase success rete by optimizing the use of available data with advanced statistical methods, offering optimal resource allocation, and maximizing benefits to patients.
Who invested in PhaseV Trials
6 investors across 2 rounds
See all investors in PhaseV Trials
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about PhaseV Trials
Who invested in PhaseV Trials?
PhaseV Trials has 6 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has PhaseV Trials raised?
PhaseV Trials has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did PhaseV Trials last raise money?
PhaseV Trials's most recent round on record is a Series A, in May 2025.
What does PhaseV Trials do?
Based in Tel Aviv, Israel, and co-founded by Raviv Pryluk (CEO), Elad Berkman (CTO), and Dan Goldstaub in 2023, PhaveV Trials Ltd.
Where is PhaseV Trials headquartered?
PhaseV Trials is headquartered in Tel Aviv, Israel.
Which VCs invest in companies like PhaseV Trials?
Among active investors with capital left to deploy, Yufu Capital, ICBC Capital Management, Ningbo Tongshang Fund and Boc Private Equity Firm back software companies at PhaseV Trials's stage. Their profiles are linked below.
VCs backing software startups at Series A
Raising like PhaseV Trials? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.